Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4653)
All Articles published online
|
Publishing Process of This Article
|
Aug 26, 2019 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cakir OO. Effectiveness of vedolizumab treatment in two different anti-tumor necrosis factor alpha refractory pouchitis: A case report. World J Clin Cases 2019; 7(16): 2316-2321 [PMID: 31531325 DOI: 10.12998/wjcc.v7.i16.2316] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i16/2316.htm |
| Number | Citing Articles |
| 1 |
Soh Okano, Naoki Yoshimura, Minako Sako, Masakazu Takazoe. A case of refractory chronic pouchitis successfully treated with tofacitinib. Clinical Journal of Gastroenterology 2020; 13(4): 560 doi: 10.1007/s12328-020-01108-5
|
| 2 |
Michaela Melde, Tanja M. Müller, Ines Schneider, Carol-Immanuel Geppert, Laura Mühl, Laura Besendorf, Clarissa Allner, Emily Becker, Imke Atreya, Francesco Vitali, Raja Atreya, Markus F. Neurath, Sebastian Zundler. α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis. Therapeutic Advances in Gastroenterology 2021; 14: 175628482110547 doi: 10.1177/17562848211054707
|